期刊文献+

单纯全视网膜光凝治疗糖尿病视网膜病变研究

Study on Pure Panretinal Photocoagulation in Treatment of Diabetic Retinopathy
下载PDF
导出
摘要 目的探讨单纯全视网膜光凝治疗糖尿病视网膜病变的临床疗效及安全性。方法选取我院2017年6月至2018年1月收治的40例糖尿病视网膜病变患者,采用单纯全视网膜光凝治疗,探讨治疗效果。结果本组患者中有24例显效,16例有效,0例无效,总有效率为100%;本组1眼术后出血,并发症率为2.5%,经过对症治疗后痊愈。结论单纯全视网膜光凝治疗可以提高糖尿病视网膜病变患者的临床治疗效果,具有较高安全性的特点,适于在临床推广使用。 Objective to investigate clinical effect and safety of pure panretinal photocoagulation in treatment of diabetic retinopathy.Methods We chose 40 patients with diabetic retinopathy admitted to our hospital from June 2017 to January 2018,treated them with panretinal photocoagulation and explore therapeutic effect.Results among patients of the group,24 cases were effective,16 cases effective,0 cases ineffective,with total effective rate of 100%;1 eye of the group had postoperative bleeding with complication rate of 2.5%,and healed after symptomatic treatment.Conclusion panretinal photocoagulation can improve clinical treatment effect of patients with diabetic retinopathy,with high safety characteristics,which is suitable for clinical application.
作者 于淼 闫桂刚 YU Miao;YAN Gui-gang(Binzhou Medical College,Binzhou,Shandong,256600;Yantai Yuhuangding Hospital,Binzhou,Shandong,256600)
出处 《智慧健康》 2021年第3期68-70,共3页 Smart Healthcare
关键词 糖尿病视网膜病变 单纯全视网膜光凝治疗 安全性 Diabetic retinopathy Pure panretinal photocoagulation Safety
  • 相关文献

参考文献11

二级参考文献98

  • 1张风.糖尿病视网膜病变激光治疗的时机与方法[J].眼科研究,2007,25(6):401-403. 被引量:41
  • 2Chen J,Snaith L E H. Retinopathy of prematurity[J]. Angiogene- sis ,2007,10(2) : 133-140.
  • 3Jang SY, Choi KS, Lee SJ. Delayed-onset retinal detachment af- teran intravitreal injection of ranibizumab for zone 1 plus reti- nopathy ofprematurity[J]. AAPOS,2010,14(5) :457-459.
  • 4Lin CJ,Chen SN,Hwang JF.Intravitrealranibizumah as salvageth- erapy in an extremely low-birth-weight infant with rush typeret- inopathy of prematurity [J]. Oman J Ophthalmol, 2012, 5 (3) : 184-186.
  • 5Shah PK.Narendran V, Tawansy KA, et al. Intravitreal bevaci-zumab(Avastin)for post laser anterior segment isehemia in ag- gressive posterior retinopathy of prematurity[J].Indian J Ophthal- tool, 2007,55 ( 1 ) : 75-76.
  • 6McNamara JA. Diode laser photocoagulation for retinopathy of prematurity, preliminary results [J]. Arch Ophthalmol, 1992, 110 (12):1714-1716.
  • 7Ahmed AE, ChannaR, Durrani J et al.Early experience with in- travitrealbevacizumab combined with laser treatment for retinopa- thy of prematurity [J].Middle East Afr J Ophthalmol, 2010, 17 (3) :264-267.
  • 8Mieieli JA, Surkont M, Smith AF.A systematic analysis of the off-label use of bevacizumab for severe retinopathy of prematu- rity[J].Am J Ophthalmol,2009,148(4):536-543.
  • 9Quiroz-Mercado,H. Antiangiogenic therapy with intravitreal bev- acizumab for retinopathy of prematurity. Retina, 2008, 28 (3) : 19-25.
  • 10Lalwani GA, Berroeal AM, Murray TG,et al. Off-label use of in- truvitreal bevaeizumah (Avastin)for salvage treatment in progres- sive threshold retinopathy of prematurity[J]. Retina, 2008, 28 (3):13-18.

共引文献105

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部